Carolina Oncology Specialists, Pa

CLIA Laboratory Citation Details

2
Total Citations
15
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 34D0246750
Address 2406 Century Place Se, Hickory, NC, 28602
City Hickory
State NC
Zip Code28602
Phone828 324-9550
Lab DirectorRICHARD ORLOWSKI

Citation History (2 surveys)

Survey - May 28, 2025

Survey Type: Standard

Survey Event ID: BQMQ11

Deficiency Tags: D5439 D6018 D6018 D5209 D5439

Summary:

Summary Statement of Deficiencies D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on review of the laboratory's policies and procedures, review of personnel records, and interview with testing personnel (TP) #1 on 5/28/25, the laboratory failed to establish policies and procedures for evaluating the competency of the technical consultant (TC) and the clinical consultants (CC). Findings: Review of the "Laboratory Quality Assurance Policy" revealed "... I. TESTING PERSONNEL ... C. Laboratory personnel will be evaluated annually by the Laboratory Director ... or the Technical Supervisor ... , and will have competency testing which will include direct observation of test being performed, running controls on analyzer, and observation of critical thinking regarding results produced. ..." The policy did not include a description of the method for evaluating TC and CC competency. Review of personnel records for the TC and the 4 CCs revealed no documentation of competency evaluation. During interview at approximately 10:20 a.m., TP #1 verified that they did not have a policy for evaluating TC and CC competency. D5439 CALIBRATION AND CALIBRATION VERIFICATION CFR(s): 493.1255(b) (b)(1) Following the manufacturer's calibration verification instructions; (b)(2) Using the criteria verified or established by the laboratory under 493.1253(b)(3)-- (b)(2)(i) Including the number, type, and concentration of the materials, as well as acceptable limits for calibration verification; and (b)(2)(ii) Including at least a minimal (or zero) value, a mid-point value, and a maximum value near the upper limit of the range to Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- verify the laboratory's reportable range of test results for the test system; and (b)(3) At least once every 6 months and whenever any of the following occur: (b)(3)(i) A complete change of reagents for a procedure is introduced, unless the laboratory can demonstrate that changing reagent lot numbers does not affect the range used to report patient test results, and control values are not adversely affected by reagent lot number changes. (b)(3)(ii) There is major preventive maintenance or replacement of critical parts that may influence test performance. (b)(3)(iii) Control materials reflect an unusual trend or shift, or are outside of the laboratory's acceptable limits, and other means of assessing and correcting unacceptable control values fail to identify and correct the problem. (b)(3)(iv) The laboratory's established schedule for verifying the reportable range for patient test results requires more frequent calibration verification. This STANDARD is not met as evidenced by: Based on review of the TOSOH AIA 900 reagent logs, review of instructions for use (IFU) for Ferritin (FER) and Carcinoembryonic Antigen (CEA) test cups and calibrator sets, lack of documentation, and interview with TP #1 on 5/28/25, the laboratory failed to perform semiannual calibration verification using at least 3 values (zero, mid-point, and upper level), for Ferritin and Carcinoembryonic Antigen in 2023 and 2024. Findings: Review of the TOSOH AIA 900 reagent logs revealed both Ferritin and CEA test cups were periodically purchased for use since 11/23/23. Review of test cup and calibrator set IFUs for Ferritin and CEA revealed the following: 1. The ST AIA-PACK FER test cup IFU states, "The following materials are required to perform analysis using the ST AIA-PACK FER on the Tosoh AIA System analyzers....AIA-PACK FER CALIBRATOR SET....." The IFU for AIA- PACK FER CALIBRATOR SET reveals two assigned ferritin levels to build a standard curve, including: a. 0 nanograms per milliliter (ng/ml) b. 500 nanograms per milliliter (ng/ml) 2. The ST AIA-PACK CEA test cup IFU states, "The following materials are required to perform analysis using the ST AIA-PACK CEA on the Tosoh AIA System analyzers....AIA-PACK CEA CALIBRATOR SET....." The IFU for AIA-PACK CEA CALIBRATOR SET reveals two assigned CEA levels to build a standard curve, including: a. 0 nanograms per milliliter (ng/ml) b. 50 nanograms per milliliter (ng/ml) Review of the TOSOH AIA 900 calibration records revealed no record of calibration verification in 2023 or 2024. During an interview at approximately 2:30 p.m., TP #1 confirmed there were no calibration verification documents for review. She stated the oversight was noted during retraining conducted by a Tosoh representative in 2025. D6018 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(iii) (e)(4)(iii) All proficiency testing reports received are reviewed by the appropriate staff to evaluate the laboratorys performance and to identify any problems that require

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 14, 2019

Survey Type: Standard

Survey Event ID: ZCNO11

Deficiency Tags: D3031 D5403 D5439 D6102 D6103 D3031 D5403 D5439 D6102 D6103

Summary:

Summary Statement of Deficiencies D3031 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(3) Analytic systems records. Retain quality control and patient test records (including instrument printouts, if applicable) and records documenting all analytic systems activities specified in 493.1252 through 493.1289 for at least 2 years. This STANDARD is not met as evidenced by: Based on review of 2017, 2018, and 2019 Abbott Cell-Dyn Ruby Hematology quality control and calibration records, and interview with testing personnel(TP) 10/14/19, the laboratory failed to retain all required records for at least two years. Findings: The laboratory performs complete blood counts with differential(CBCD) testing on 2 Cell- Dyn Ruby Hematology analyzers. Hematology analyzer #1 is located in the main lab. Hematology analyzer #2 is located in the treatment room. 1. Review of the Hematology quality control records revealed the laboratory failed to retain quality control assay sheets listing acceptable ranges for the following lot numbers: a. Cell- Dyn 26 Plus Control- lot #7254, in use 9/28/17- 11/24/17; b. Cell-Dyn 26 Plus Control-lot #8113, in use 5/11/18-7/6/18. 2. Review of Hematology calibration records revealed the laboratory failed to retain calibration assay sheets for the following lot number: a. HemCal Plus Calibrator- lot CD8141, used for calibrations performed on 6/29/18. During interview at approximately 2:30 p.m., TP#6 confirmed the records were not available. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 4 -- examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access